Ajuts a la recerca

Ovarian Cancer Research Program Teal Innovator Award

Organisme

Applications to the Fiscal Year 2013 (FY13) Ovarian Cancer Research Program (OCRP) are being solicited for the Assistant Secretary of Defense for Health Affairs, Defense Health Program (DHP), by the U.S. Army Medical Research Acquisitions Activity (USAMRAA). Appropriations for the OCRP from FY97 through FY12 totaled $196.45 million (M). The FY13 appropriation is $20M. The overall goal of the FY13 OCRP is to eliminate ovarian cancer by supporting innovative, high-impact research.

Objecte

The OCRP’s long-term priorities are as follows:
• Understand precursor lesion/stem cell, microenvironment, and pathogenesis/progression of ovarian cancer;
• Improve performance and reliability of disease markers and imaging toward screening and selecting the best therapeutic approaches;
• Address issues in survivorship;
• Enhance pool of ovarian cancer scientists; and
• Investigate tumor response to therapy including tumor survival, dormancy, cell death, clonal evolution, tumor heterogeneity.
 

The OCRP Teal Innovator Award supports a visionary individual from any field principally outside of, but not exclusive of, ovarian cancer to focus his/her creativity, innovation, and leadership on ovarian cancer research. The Teal Innovator Award will provide the Principal Investigator (PI) with the funding and freedom to pursue his/her most novel, visionary, high-risk ideas that could significantly impact the field of ovarian cancer research or patient care. The proposed Teal Innovator must be highly recognized in his/her field and present evidence of this recognition. Examples include, but are not limited to, recognition at the level of endowed chair; membership in the National Academy of Sciences, National Academy of Engineering, or Institute of Medicine; Chairmanship of the American Association for Cancer Research; or other national or international recognition.
 

Termini oficial

Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), June 12, 2013
Confidential Letters of Recommendation Submission Deadline: 5:00 p.m. ET, August 28, 2013
Invitation to Submit an Application: July 2013
Application Submission Deadline: 11:59 p.m. ET, August 28, 2013
Peer Review: October 2013
Programmatic Review, Stage 1: November 2013
Invitation for Oral Presentation: November 2013
Programmatic Review, Stage 2: December 2013

Termini IISPV

Cal comunicar abans del 30 de maig 2013 que es vol participar a la convocatòria, enviant un e-mail a europa@iispv.cat . Termini: 06 de juny de 2013

Pujar